Abbott Laboratories is taking its weight reduction drug Meridia (sibutramine) off the market, based on the U.S. Meals and Drug Administration.
The corporate voluntarily withdrew the drug within the wake of findings displaying an elevated threat of coronary heart assaults and strokes in individuals who used the drug. Meridia is taken by about 8 million individuals worldwide.
In response to Paging Dr. Gupta:
“Permitted in 1997 for weight reduction, the unique knowledge on the drug confirmed that individuals who took Meridia misplaced at the least 5 % extra of their physique weight …
The FDA requested the corporate withdraw the drug after reviewing knowledge from a follow-up research often called the Sibutramine Cardiovascular Outcomes Trial (SCOUT ). It confirmed there was a 16 % enhance within the threat of significant coronary heart occasions.”
Supply hyperlink
